Wintermute Biomedical
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 4317, Hawker, Australian Capital ...Phone Number
(406) 207-1078Website
www.wintermutebiomedical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Wintermute Biomedical
Wintermute Biomedical is a research-led company focused on developing investigational antiviral treatments, particularly Solexan, for shingles and related pain. They prioritize patient safety and real-world relevance through evidence-driven clinical trials in collaboration with clinicians and academic partners. The company also aims to address antibiotic-resistant diseases by leveraging their patented fatty acid formulations for clinical applications. Their commitment to transparency and rigorous ethics underpins their innovative approach to improving disease management and patient outcomes.Explore more
Wintermute Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Wintermute Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Wintermute Biomedical is spiking on competitors!
Click to see if Wintermute Biomedical had a recent Job posting/layoffs
Product Launch: Get notified when Wintermute Biomedical launches new products
Earning: See what the market has to say on Wintermute Biomedical recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Wintermute Biomedical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Wintermute Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Wintermute Biomedical has new funding data
Website visits: Recent activity has been detected on your website
Check if Wintermute Biomedical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Wintermute Biomedical
Compare insights from companies similar to Wintermute Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.1M
11-50
Private
-
2015
GM
Garry MyersProfessor, Director, Australian Institute for Microbiology and Infection, UTS
Company Profile Activity
Activity Insights
Wintermute Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Wintermute Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Wintermute Biomedical.
Wintermute Biomedical Tech Stack
A closer look at the technologies used by Wintermute Biomedical
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Wintermute Biomedical
Sign Up For FreeTo access detailed company insights
Wintermute Biomedical is a research-led company focused on developing investigational antiviral treatments, particularly Solexan, for shingles and related pain. They prioritize patient safety and real-world relevance through evidence-driven clinical trials in collaboration with clinicians and academic partners. The company also aims to address anti... Read More
